1012179

Ariad Pharmaceuticals — FEI 1000513233

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 31, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cambridge, MA (United States)